Caroline Arquizan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Caroline Arquizan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Emmanuel Touzé
Université Caen Normandie - UNICAEN, INSERM, PhIND (Physiopathology and Imaging of Neurological Disorders), Institut BBM@C (Brain, Blood and Memory @ Caen Normandie), Cyceron, Caen, France
1 shared publication France Woimant
1 shared publicationJean-François Meder
1 shared publicationJean-Louis Mas
1 shared publication- Jean-Louis Mas
From the Neurology Department (C.L., C.G., M.Z., C.A., J.L.M.) and Neuroradiology Department (J.F.M., D.T.), Sainte-Anne Hospital, and Department of Biostatistics, Cochin Hospital (J.C.), Paris V University, Paris, France
1 shared publication Patent Foramen Ovale and Atrial Septal Aneurysm Study Group
1 shared publication
Latest Publications
- 1 July 2005
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 20 (1) , 41-45
Blood Pressure, Smoking and Oral Contraceptive Control after Cryptogenic Stroke in Young Adults in the PFO-ASA Study
Background: Management of vascular risk factors is not optimal in stroke patients. We assessed the control of hypertension, smoking and stopping of oral contraceptive in 581 consecutive young cryptogenic ischemic stroke patients followed in the PFO-ASA study and we identified factors associated with inadequate management. Methods: At each follow-up visit, blood pressure (BP), smoking and use of oral contraceptive were recorded. Data were analyzed at 6 months, 1 and 2 years. Hypertension was defined as systolic BP ≧140 or diastolic BP ≧90 mm Hg, recorded in at least two follow-up visits. Current smoking was defined as more than one cigarette per day reported during at least one follow-up visit. Results: During follow-up, 36% of patients were hypertensive and 30% were smokers. Among the 90 hypertensive patients at baseline, 60–68% remained with high BP and among the 278 patients who were current smokers at baseline, 54–58% still smoked during follow-up. Age (OR = 1.05, 95% CI 1.02–1.08), male sex (OR = 1.42, 95% CI 0.93–2.18), body mass index ≧27 (OR = 2, 95% CI 1.27–3.17) and known hypertension (OR = 3.08, 95% CI 1.80–5.28) were significantly associated with hypertension during follow-up. Tobacco consumption at baseline (OR = 35.2, 95% CI, 19.3–64.2), alcohol consumption at baseline (OR = 2.7, 95% CI 1.4–5.2) and Rankin ≤2 (OR = 2.6, 95% CI 1.4–4.9) were independently associated with persistent smoking. Among the 114 women who were using combined estrogen-progesterone pills at baseline, 96.5% stopped. Conclusions: Major risk factors for stroke are poorly controlled after stroke, even in the context of a prospective clinical study in young adults.
- 1 July 2005
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 20 (1) , 41-45
Blood Pressure, Smoking and Oral Contraceptive Control after Cryptogenic Stroke in Young Adults in the PFO-ASA Study
Background: Management of vascular risk factors is not optimal in stroke patients. We assessed the control of hypertension, smoking and stopping of oral contraceptive in 581 consecutive young cryptogenic ischemic stroke patients followed in the PFO-ASA study and we identified factors associated with inadequate management. Methods: At each follow-up visit, blood pressure (BP), smoking and use of oral contraceptive were recorded. Data were analyzed at 6 months, 1 and 2 years. Hypertension was defined as systolic BP ≧140 or diastolic BP ≧90 mm Hg, recorded in at least two follow-up visits. Current smoking was defined as more than one cigarette per day reported during at least one follow-up visit. Results: During follow-up, 36% of patients were hypertensive and 30% were smokers. Among the 90 hypertensive patients at baseline, 60–68% remained with high BP and among the 278 patients who were current smokers at baseline, 54–58% still smoked during follow-up. Age (OR = 1.05, 95% CI 1.02–1.08), male sex (OR = 1.42, 95% CI 0.93–2.18), body mass index ≧27 (OR = 2, 95% CI 1.27–3.17) and known hypertension (OR = 3.08, 95% CI 1.80–5.28) were significantly associated with hypertension during follow-up. Tobacco consumption at baseline (OR = 35.2, 95% CI, 19.3–64.2), alcohol consumption at baseline (OR = 2.7, 95% CI 1.4–5.2) and Rankin ≤2 (OR = 2.6, 95% CI 1.4–4.9) were independently associated with persistent smoking. Among the 114 women who were using combined estrogen-progesterone pills at baseline, 96.5% stopped. Conclusions: Major risk factors for stroke are poorly controlled after stroke, even in the context of a prospective clinical study in young adults.
- 31 March 2004
- Vol. 54 (6) , 637-40
[Hypertension in the acute phase and in the secondary prevention of stroke].
Elevated blood pressure (BP) is frequent after acute stroke and almost 40% of patients remain hypertensive over a period of about a week. There is no data from controlled trials concerning management of hypertension in the acute phase of stroke. Theorical beneficial effects of acutely lowering BP seems lower that risk of deterioration of ischemic brain tissue. Current acute ischemic stroke guidelines suggest that unless systolic BP exceeds an cutoff of 220 mmHg or diastolic exceeds 120 mmHq, it should be tolerated, except in planned thrombolytic therapy. In case of hemorragic stroke, the cutoff should be of 185/110 mmHg. Prudence suggests that BP should be lowered carefully. In secondary prevention of stroke, the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) demonstrated that a blood pressure-lowering regimen, involving a angiotensin-converting enzyme inhibitor and a diuretic, reduced the risks of stroke of 28% and of other major vascular events of 26% among individuals with a history of cerebrovascular disease. Every patient with a history of stroke should be treated with the association.
- 31 March 2004
- Vol. 54 (6) , 637-40
[Hypertension in the acute phase and in the secondary prevention of stroke].
Elevated blood pressure (BP) is frequent after acute stroke and almost 40% of patients remain hypertensive over a period of about a week. There is no data from controlled trials concerning management of hypertension in the acute phase of stroke. Theorical beneficial effects of acutely lowering BP seems lower that risk of deterioration of ischemic brain tissue. Current acute ischemic stroke guidelines suggest that unless systolic BP exceeds an cutoff of 220 mmHg or diastolic exceeds 120 mmHq, it should be tolerated, except in planned thrombolytic therapy. In case of hemorragic stroke, the cutoff should be of 185/110 mmHg. Prudence suggests that BP should be lowered carefully. In secondary prevention of stroke, the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) demonstrated that a blood pressure-lowering regimen, involving a angiotensin-converting enzyme inhibitor and a diuretic, reduced the risks of stroke of 28% and of other major vascular events of 26% among individuals with a history of cerebrovascular disease. Every patient with a history of stroke should be treated with the association.
- 24 May 2001
- Published by Cambridge University Press (CUP)
- p. 626-650
Brain venous thrombosis syndromes
The syndrome of intracranial vein and sinus thrombosis or cerebral venous thrombosis (CVT) has been recognized since the early part of the nineteenth century, when Ribes (1825) described the clinical and autopsy findings in a 45- year-old man with disseminated malignancy and thrombosis of the superior sagittal sinus (SSS), left lateral sinus (LS), and a cortical vein. For a long time, CVT was considered a rare disease associated with a poor prognosis, and because confirmation was by autopsy initially, only severe manifestations were recognized (Ehlers & Courville, 1936; Symonds, 1937; Garcin & Pestel, 1949; Barnett & Hyland, 1953; Kalbag & Woolf, 1967; Krayenbuhl, 1967). Since the 1970s, the advent of sensitive neuroimaging techniques has clearly added to our understanding, earlier diagnosis and management of this condition, with effective treatments for both thrombosis and its underlying causes (Ameri & Bousser, 1992).Venous anatomyThe intracranial venous system is considerably more variable than the arterial anatomy (Figs. 50.1 and 50.2). Blood from the brain is drained by cerebral veins which empty into dural sinuses, themselves drained mostly by internal jugular veins.VeinsCortical cerebral veinsThese veins receive blood from the superficial medullary veins that begin about 2 cm beneath the cortex. They drain the cortex and the adjacent white-matter. The cortical cerebral veins can be subdivided into three groups, based on the venous sinus into which they empty (Lasjaunias & Berenstein, 1990): (i) a dorsomedial system draining the high convexity and midline cortical veins, mainly into the SSS or the inferior sagittal sinus; (ii) a posteroinferior (ventrolateral) group draining temporo-occipital cortical veins into the LS;
- 24 May 2001
- Published by Cambridge University Press (CUP)
- p. 626-650
Brain venous thrombosis syndromes
The syndrome of intracranial vein and sinus thrombosis or cerebral venous thrombosis (CVT) has been recognized since the early part of the nineteenth century, when Ribes (1825) described the clinical and autopsy findings in a 45- year-old man with disseminated malignancy and thrombosis of the superior sagittal sinus (SSS), left lateral sinus (LS), and a cortical vein. For a long time, CVT was considered a rare disease associated with a poor prognosis, and because confirmation was by autopsy initially, only severe manifestations were recognized (Ehlers & Courville, 1936; Symonds, 1937; Garcin & Pestel, 1949; Barnett & Hyland, 1953; Kalbag & Woolf, 1967; Krayenbuhl, 1967). Since the 1970s, the advent of sensitive neuroimaging techniques has clearly added to our understanding, earlier diagnosis and management of this condition, with effective treatments for both thrombosis and its underlying causes (Ameri & Bousser, 1992).Venous anatomyThe intracranial venous system is considerably more variable than the arterial anatomy (Figs. 50.1 and 50.2). Blood from the brain is drained by cerebral veins which empty into dural sinuses, themselves drained mostly by internal jugular veins.VeinsCortical cerebral veinsThese veins receive blood from the superficial medullary veins that begin about 2 cm beneath the cortex. They drain the cortex and the adjacent white-matter. The cortical cerebral veins can be subdivided into three groups, based on the venous sinus into which they empty (Lasjaunias & Berenstein, 1990): (i) a dorsomedial system draining the high convexity and midline cortical veins, mainly into the SSS or the inferior sagittal sinus; (ii) a posteroinferior (ventrolateral) group draining temporo-occipital cortical veins into the LS;